Pharmacokinetic herb‐drug interaction between ginger and crizotinib

The use of complementary and alternative medicine at least once during or after cancer treatment has increased over the past years from an estimated 25% in the 1970s and 1980s to more than 32% in the 1990s and to 49% after 2000. The risk of herb‐drug interaction is therefore increasingly recognized...

Full description

Saved in:
Bibliographic Details
Published in:Br J Clin Pharmacol
Main Authors: Revol, Bruno, Gautier‐Veyret, Elodie, Arrivé, Capucine, Fouilhé Sam‐Laï, Nathalie, McLeer‐Florin, Anne, Pluchart, Hélène, Pinsolle, Julian, Toffart, Anne‐Claire
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2019
Subjects:
Letter to the Editor
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7444772/
https://ncbi.nlm.nih.gov/pubmed/30701569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13862
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items